Notably, the TCR repertoire exhibited more pronounced changes than the BCR repertoire, with 773 differentially expressed CDR3s compared to only 21 in BCR, suggesting that TCR may play a more central role in anti-tumor immunity and could serve as a more sensitive indicator of malignant transformation. This evidence concerns the gene BCR and neoplasm.